Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
This profile was auto-generated from public COAs. Claim it to start uploading verified COAs directly — free forever.
Profile auto-generated from public COAs. Based in US.
What fraction of this lab's COAs report each test type. Real third-party labs typically run a consistent panel; sparse coverage on safety tests (endotoxin, sterility) is a common signal of HPLC-only purity work.
| Vendor | Peptide | Lot | Purity | Endo | Tested | |
|---|---|---|---|---|---|---|
| Reta One Labs | Retatrutide | R30725 | — | ✓ | — | View |
| Reta One Labs | Retatrutide | R50725 | 99.68% | — | — | View |
| Reta One Labs | Retatrutide | R601025 | 99.80% | — | — | View |
| Reta One Labs |
| Tirzepatide |
| TR300925 |
| 99.80% |
| — |
| — |
| View |
| Reta One Labs | Tirzepatide | TR301025 | 99.88% | — | — | View |
| Reta One Labs | Tesamorelin | TS101125 | 99.34% | — | — | View |
| Reta One Labs | Retatrutide | R50725 | 99.68% | — | — | View |
| Reta One Labs | Retatrutide | RT300326 | 99.80% | — | — | View |
| Reta One Labs | Retatrutide | R601025 | — | ✓ | — | View |
| Reta One Labs | Retatrutide | R61025 | 99.48% | — | — | View |
| Reta One Labs | Tirzepatide | TR300925 | 99.80% | — | — | View |
| Reta One Labs | Tirzepatide | TZ100326 | 99.80% | — | — | View |
| Reta One Labs | BPC-157 | BP100925 | 99.80% | ✓ | — | View |
| Reta One Labs | KLOW | KL801025 | 99.00% | — | — | View |
| Reta One Labs | Semaglutide | SM100326 | 99.76% | — | — | View |
| Reta One Labs | NAD+ | NAD112025 | 99.00% | — | — | View |
| Reta One Labs | Tesofensine | TES500925 | — | — | — | View |
| Prime Peptides | Semaglutide | 2122026SM | 99.02% | ✓ | — | View |
| Reta One Labs | Retatrutide | R601025 | 99.80% | — | — | View |
| Reta One Labs | Tesamorelin | TS101125 | 99.34% | — | — | View |
| Reta One Labs | Tesamorelin | TS100326 | 99.12% | — | — | View |
| Prime Peptides | MOTS-C | 11242025MO | 99.05% | ✓ | — | View |
| Reta One Labs | Retatrutide | RT100326 | 99.80% | — | — | View |
| Reta One Labs | Retatrutide | R61025 | 99.48% | — | — | View |
| Reta One Labs | Retatrutide | R20725 | — | ✓ | — | View |
| Reta One Labs | Retatrutide | R10725 | — | ✓ | — | View |
| Reta One Labs | Retatrutide | R401125 | 99.80% | — | — | View |
| Reta One Labs | Retatrutide | R30725 | — | ✓ | — | View |
| Reta One Labs | Retatrutide | R601025 | — | ✓ | — | View |
| Reta One Labs | Tirzepatide | TZ100326 | 99.80% | — | — | View |
| Reta One Labs | Tesamorelin | TS100326 | 99.12% | — | — | View |
| Reta One Labs | BPC-157 | BP100925 | 99.80% | ✓ | — | View |
| Reta One Labs | KLOW | KL801025 | 99.00% | — | — | View |
| Reta One Labs | GHK-Cu Serum | — | — | — | — | View |
| Reta One Labs | Retatrutide | RT100326 | 99.80% | — | — | View |
| Reta One Labs | Retatrutide | R10725 | — | ✓ | — | View |
| Reta One Labs | Retatrutide | RT200326 | 99.80% | — | — | View |
| Reta One Labs | Retatrutide | R401125 | 99.80% | — | — | View |
| Reta One Labs | Retatrutide | R20725 | — | ✓ | — | View |
| Reta One Labs | Retatrutide | RT300326 | 99.80% | — | — | View |
| Reta One Labs | GLOW | GL700326 | 99.50% | — | 2026-02-23 | View |
| Reta One Labs | Semaglutide | SM100326 | 99.76% | — | 2026-02-23 | View |
| Reta One Labs | Semaglutide | SM200326 | 99.31% | — | 2026-02-23 | View |
| Reta One Labs | MOTS-C | MTS100326 | 99.06% | — | 2026-02-23 | View |
| Reta One Labs | MOTS-C | MTS100326 | 99.06% | — | 2026-02-23 | View |
| Reta One Labs | GLOW | GL700326 | 99.50% | — | 2026-02-23 | View |
| Reta One Labs | Semaglutide | SM200326 | 99.31% | — | 2026-02-23 | View |
| Reta One Labs | GHK-Cu Serum | — | — | — | 2025-12-01 | View |
| Reta One Labs | NAD+ | NAD112025 | 99.00% | — | 2025-11-12 | View |
| Reta One Labs | Tesofensine | TES500925 | — | — | 2025-10-10 | View |
Disclosed Labs